Results 81 to 90 of about 101,889 (202)

Complete Remission of Acute Myeloid Leukemia in Induction and Consolidation Chemotherapy without Bone Marrow Transplantation: Lessons Learned from Good Presentation Case

Majalah Kedokteran Bandung, 2019
Acute myeloid leukemia (AML) is a clinically morphologically and genetically heterogeneous disease with variable responses to therapy. The majority of the patients eventually relapse and succumb to the disease.
Tuti Sri Hastuti, Rachmat Sumantri, Indra Wijaya   +2 more
doaj   +1 more source

A Case of Rituximab Use as an Induction and Maintenance of Remission in ANCA-Associated Vasculitis [PDF]

, 2016
Antineutrophil cytoplasmic antibody- (ANCA-) associated vasculitis (AAV) is a multisystem autoimmune disease affecting mainly microscopic blood vessels due to circulating autoantibodies against neutrophil cytoplasmic antigens.
Shahd Hafiz, Neveen Awad, Hani Almoallim, Abdurahman Albeity   +3 more
core   +1 more source

Enteral nutrition feeding strategies and their impact on relapse rate and quality of life in paediatric Crohn’s disease

, 2010
MDAims: To study induction of remission and reduction in relapse rate of childhood Crohn’s disease with quality of life (QOL) assessment in subjects on long term continuous oral supplementation with ACD004.
Afzal, Nadeem Ahmad
core  

Complete remission achieved with ATRA as single induction agent for patient #18.

, 2019
Complete remission achieved with ATRA as single induction agent for patient #18.
Luis Fernando Mello (7252421), Eduardo M. Rego (7252424), Gerson Hiroshi Yoshinari Jr (7252415), Artur César Fassoni (7252418)   +3 more
core   +1 more source

Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X.

, 1996
The benefits of achieving a long term event free survival of 60-70% by using increasingly intense treatment regimens must be weighed against the increased risk of treatment toxicity.
Wheeler, K, Richards, SM, Bailey, CC, Chessells, JM   +3 more
core   +1 more source

Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis:a randomised, non-inferiority trial [PDF]

, 2019
Objectives Cyclophosphamide induction regimens are effective for antineutrophil cytoplasmic antibody (ANCA)- associated vasculitis (AAV), but are associated with infections, malignancies and infertility.
Vaglio, A, Tesar, Vladimir, Espigol-Frigolé, Georgína, Peh, Chen Au, Jayne, David, Walters, Giles, Bruchfeld, Annette, Walsh, D, Walsh, Dorothy, Brogan, P, Tesar, V, Espigol-Frigolé, G, Brogan, Paul, Walters, G, Dahlsveen, Karen, Vaglio, Augusto, European Vasculitis Study Group (EUVAS), Bruchfeld, A, Walsh, Michael, Peh, CA, Jones, RB, Dahlsveen, K, De Zoysa, J, Engelbert Blockmans, Daniel, Lanyon, P, Blockmans, DE, Ballarin, J, Cid, MC, Harper, L, Walsh, M, Hiemstra, TF, Jones, Rachel B., Ballarin, Jose, de Zoysa, Janak, Hiemstra, Thomas F, Cid, Maria C., Lanyon, Peter, Jayne, D, Harper, Lorraine   +38 more
core   +1 more source

Clinical Evaluation of Risankizumab in the Treatment of Adults with Moderately to Severely Active Crohn’s Disease: Patient Selection and Reported Outcomes

Drug Design, Development and Therapy, 2023
Sara Horst,1 Raymond K Cross2 1Vanderbilt University Medical Center, Nashville, TN, USA; 2University of Maryland School of Medicine, Baltimore, MD, USACorrespondence: Sara Horst, Vanderbilt University Medical Center, Inflammatory Bowel Disease Clinic ...
Horst S, Cross RK
doaj  

Re-induction of complete remission, subsequent relapses and adverse events in relapsed cases.

, 2018
Re-induction of complete remission, subsequent relapses and adverse events in relapsed cases.
Yoshinari Yasuda (588830), Takaya Ozeki (4568404), Masahiko Ando (579876), Takayuki Katsuno (588826), Sawako Kato (588825), Shoichi Maruyama (363455), Makoto Yamaguchi (588823), Naotake Tsuboi (588829)   +7 more
core   +1 more source

Outcomes of Pediatric Patients with Crohn's Disease Received Infliximab or Exclusive Enteral Nutrition during Induction Remission

, 2022
BACKGROUND: Both exclusive enteral nutrition (EEN) and infliximab (IFX) are recommended as induction therapy for pediatric Crohn's disease (CD). Our aim was to compare long-term disease outcomes of patients initially received with either IFX or EEN ...
Peng, Kerong, Hong Zhao, Fang, Youhong, Jingan Lou, Jindan Yu, Cheng, Qi, Jie Chen, Yao Lv, Lou, Jingan, Yue Lou, Lou, Yue, Chen, Jie, Zhao, Hong, Kerong Peng, Youhong Fang, Luo, Youyou, Yang, Gan, Lv, Yao, Qi Cheng, Yu, Jindan, Gan Yang, Youyou Luo   +21 more
core   +1 more source

Induction of remission in autoimmune polyglandular syndrome type three (APS III): An old drug with new perspectives

Clinical Case Reports, 2018
Key Clinical Message The autoimmune polyglandular syndrome is a sequential chain of autoimmune events. Whenever diagnosed, the clinician's target should be induction of remission and if possible hindering its progression especially if associated with ...
Magdy Mohamed Allam, Hanaa Tarek Hussein Elzawawy   +1 more
doaj   +1 more source